What is tedizolid phosphate (tablets) used for?
Tedizolid phosphate tablets are an antibiotic in the oxazolidinone class used to treat certain acute bacterial skin and skin structure infections (ABSSSI) in adults. Clinical development data focus on efficacy and safety in ABSSSI populations [1][2].
What do the main clinical trial results say?
The core evidence base for tedizolid phosphate tablets comes from Phase 3 ABSSSI studies comparing tedizolid to standard-of-care antibiotics (and/or to other regimens). Published reports describe similar or improved clinical response rates versus comparator therapy, alongside safety and tolerability findings typical for the class (including gastrointestinal effects and headache as commonly reported events) [1][2].
How is tedizolid phosphate different from linezolid?
Tedizolid and linezolid are both oxazolidinone antibiotics, but they differ in dosing frequency and some pharmacologic properties. In ABSSSI trials, tedizolid was studied as a once-daily regimen, while linezolid is commonly dosed more than once daily. Comparative literature also discusses differences in adverse event profiles and treatment convenience, though patients should follow the specific prescribing information for their condition and risk factors [1][2].
What safety and drug-interaction issues come up in the literature?
Across published trial and review literature, common adverse effects reported for tedizolid include gastrointestinal symptoms (for example, nausea) and headache. The oxazolidinone class is also discussed in the literature for potential drug interaction considerations (the type of interactions depends on the exact agent and regimen studied), so prescribers rely on the full drug label and interaction guidance when selecting therapy [1][2].
What does “tedizolid phosphate tablets literature” usually include?
When people search for this phrase, they typically mean one or more of the following categories of sources:
- Trial publications for ABSSSI efficacy and safety [1][2]
- Review articles summarizing the drug’s role in skin infections and how it compares with other antibiotics in the class [1][2]
- Labeling/regulatory documentation that consolidates dosing, contraindications, warnings, and pharmacology details for tablets [3]
If you tell me whether you need peer‑reviewed papers only, or also the prescribing information/label, I can narrow the list to exactly the type of “literature” you’re after.
Where can I find authoritative sources (papers + label)?
Authoritative starting points for tedizolid phosphate tablet information include:
- Published Phase 3 and clinical studies (efficacy and safety) [1][2]
- The official prescribing information for dosing and safety/interaction details [3]
Sources
1. https://pubmed.ncbi.nlm.nih.gov/?term=tedizolid+phosphate+ABSSSI+phase+3
2. https://pubmed.ncbi.nlm.nih.gov/?term=tedizolid+phosphate+tablet+study
3. https://www.accessdata.fda.gov/scripts/cder/daf/